本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

63.36
-2.3900-3.63%
成交量:121.06万
成交额:7,775.50万
市值:124.06亿
市盈率:-17.75
高:66.05
开:66.05
低:63.33
收:65.75
52周最高:93.42
52周最低:52.75
股本:1.96亿
流通股本:1.67亿
量比:0.72
换手率:0.72%
股息:- -
股息率:- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
净资产收益率:-1789.67%
总资产收益率:-26.00%
市净率:-4.93
市盈率(LYR):-16.74

数据加载中...

2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/26

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/25

SEC问询函

[Cover]Correspondence
2019/06/24

SEC问询函

[Cover]Correspondence
2019/06/24

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/17

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/11

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/05/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/29

持股变动声明

Statement of changes in beneficial ownership of securities
2019/05/24

招股说明书

General form for registration of securities under the Securities Act of 1933
2018/12/13

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/12

持股变动声明

Statement of changes in beneficial ownership of securities